Clinical Trial Update: Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of gemcitabine, oxaliplatin, and bevacizumab in hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Avastin (bevacizumab)
• Eloxatin (oxaliplatin)
• Gemzar (gemcitabine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED